Skip to main content
. 2020 May 18;5(Suppl 3):e000804. doi: 10.1136/esmoopen-2020-000804

Table 4.

Priorities for pancreatic cancer: medical oncology in localised and locally advanced disease

High priority Medium priority Low priority
Initiation of neoadjuvant or adjuvant treatment not yet initiated Adjuvant treatment to be initiated, if patient condition after surgery has not recovered (to be postponed only within 12 weeks from surgery) Follow-up imaging and restaging studies in asymptomatic patients, taking into account pathological stage
Completion of neoadjuvant or adjuvant treatment that has already been initiated In case of elderly patients with cardiovascular or other comorbidities not fit for a triple regimen, evaluate risk/benefit ratio of a mono-chemotherapy
Continuation of treatment in the context of clinical trial